Pulmonary hypertension, Interstitial lung disease Pulmonary hypertension, Interstitial lung disease
Conditions
Interventions
None listed
Sponsors
Tsujino Ichizo
Chiang Jason
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Male or female who are >=20 years of age at the time of initial PH or ILD diagnosis. 2.With a diagnosis of PAH, ILD-PH, or ILD-no PH at the time of study entry 3.Individuals who voluntarily consent to participate in the study with sufficient understanding after receiving a detailed explanation of it
Exclusion criteria
Exclusion criteria: 1.Patients who are diagnosed with PH, but classified as group 2, 4, or 5 2.Patients who are classified as group 3 PH without PAH, but have received medication for PAH before baseline 3.Patients who are diagnosed with ILD, the state of which is however expected to change rapidly, including respiratory infection, and drug-induced pneumonia 4.[Prevalent patient only] patients whose first ILD or PH diagnosis was before January 1, 2010. 5.Other individuals who, in the opinion of the sponsor, are not appropriate patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary vascular resistance | — |
Secondary
| Measure | Time frame |
|---|---|
| Data of right heart catheterization, cardiac MRI, respiratory function test, echocardiography, chest CT, urine/blood test, genetic test, biomarker, questionnaire | — |
Contacts
Public ContactIchizo Tsujino
Hokkaido University
Outcome results
None listed